Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pinter

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
JCI Insight|December 22, 2025
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasisDavid Strawn, James G Krueger, Robert Bissonnette, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa CohortKelsey R van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 24, 2026
Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativaGeorgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
JCI Insight|December 22, 2025
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasisDavid Strawn, James G Krueger, Robert Bissonnette, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa CohortKelsey R van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 24, 2026
Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativaGeorgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, et al.
Pageof 14